Corporate Social Responsibility

Our mission to make affordable biologics accessible is inherently social, and we partner with governments and civil society to drive sustainable change.

Biocon Foundation leads our philanthropic efforts in India, supporting disadvantaged and marginalized communities through resilient, need-based solutions. To identify genuine community concerns and develop suitable projects, we conduct comprehensive needs assessments across focus areas—health, education, rural development, women’s empowerment, research, and environment—using data analysis, community surveys, discussions, and stakeholder interviews. Partners are selected via a structured grant process to implement projects effectively. Our investments support healthcare access, innovation, clinical excellence, and green urban mobility.

Biocon Foundation has run a multi-state, flagship oral cancer screening program successfully for almost a decade, positively impacting more than 75,000 beneficiaries.

  • Implemented across select sites in Uttar Pradesh, Rajasthan, Punjab, Assam, Maharashtra, and Karnataka.
  • Focuses on reducing the burden of oral cancer through technology, training, and collaboration.
  • Uses a mobile app operated by trained frontline health workers for OPMD (Oral Potentially Malignant Disorders) screening and surveillance.
  • Engages government and state-specific NGOs for effective execution.
  • Led to the formation of an independent Oral Cancer Task Force (OCTF) to ideate, educate, and engage stakeholders.
  • Future goal: Integrate AI-driven analysis of clinical, imaging, cytology, pathology, genomics, and proteomics data into a unique, multidimensional platform.

Biocon Foundation supported the construction of the Biocon-Syngene General Medicine Wing at IISc’s Postgraduate Medical School & Hospital in Bengaluru.

  • The new wing will span six floors and house 147 beds.
  • A unique MBBS/MPH Internship program has been introduced to promote interdisciplinary research and develop physician-scientists.
  • 37 selected students interned under 35 faculty members at IISc, Bengaluru, for 1–2 months.
  • Key research areas included: Cancer Biology, Bioengineering, Artificial Intelligence and Data Sciences, Endocrinology, and Biomedical Devices

Biocon Foundation contributed ₹650 million to Bangalore Metro Rail Corporation Limited (BMRCL) for the Biocon-Hebbagodi Metro station on Hosur Road, part of the 18.82-km elevated Yellow Line connecting RV Road and Bommasandra. The Metro offers sustainable, efficient transport, easing traffic and reducing pollution. The Foundation also transformed the space under the corridor with pier wall paintings reflecting Karnataka’s heritage and introduced median gardens, merging urban aesthetics, art, and environment

 

To know more about how we generated value that goes beyond commercial operations, click here.

Related Links

Responsibility

We are committed to creating positive, lasting change for patients, communities, and the planet. Through a powerful ESG (Environmental, Social,...
Read More

Governance

Our governance philosophy is deeply rooted in integrity, transparency, accountability, and ethical decision-making, which guide our actions and relationships....
Read More

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree